EUVIMEDEUVIMED entdecken
Crossref

Does patients’ age influence 5-year survival in intrahepatic cholangiocarcinoma?

A. Bauschke, A. Altendorf-Hofmann, A. Ali-Deeb, F. Dondorf, F. Rauchfuß, O. Rohland, U. Settmacher

Zeitschrift für Gastroenterologie · 01.09.2024 · 62 (09) · e702-e703

DOI: 10.1055/s-0044-1789863 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.09.2024. Verfasst von A. Bauschke und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intrahepatic cholangiocarcinoma is the second most common primary liver tumor. The aim of this study is to find prognostic factors for intrahepatic cholangiocarcinoma considering patient’s age, Material/ methods: We reviewed the records of 403 consecutive patients with iCC introduced to our department from 1995 to 2021. Cases with mixed HCC and iCC and the cases without histological proof of iCC were not included in statistical analyses. Treatment decisions for all patients were made in an interdisciplinary conference. Follow-up time was 92 months.

Results

We included 403 tumors diagnosed as diagnosed as iCC (8160/3) by the pathologist. Patients with iCC were female in 43%, 23% of iCC tumors had distant metastases at diagnosis. Systemic therapy only or best supportive care was given to more than one third of the iCC patients (37%). Between 1995 and 2009 we saw 141 patients, between 2010 and 2021 we saw 262 patients. Dependent on age we divided patients in three groups < 50 years (41 patients), 50-69 years (237 patients) and ≥70 years (125 patients). Table 1 All n Age ≤49 Age 50-69 Age ≥70 p Year of diagnosis 1995-2009 141 11% 67% 22% 0,015 2010-2021 262 10% 54% 36% Number of lesions Solitary 207 46% 51% 56% 0,471 Multiple 192 54% 49% 44% Therapy Partial hepatectomy/LTX 148 32% 39% 34% 0,611 Local therapy 31 12% 7% 7% No local therapy 224 56% 54% 59% M category M0 310 71% 76% 81% 0,355 M1 93 29% 24% 19% The number of patients ≥70 years of age increased statistically significant during the study time from 22% to 36%. Among all 403 patients number of lesions, type of therapy and number of patients with distant metastases were not statistically significant different between age groups (table). 44 of 138 resected patients with with iCC have survived for more than 5 years. The crude 5 year survival rate was 28% for all patients and did not differ statistically significant for the three age groups (10%, 27% and 34%, respectively). There was only a trend to better survival for the rest of the patients in comparison to the group of younger patients (p=0.082). In a multivariate Analysis including age, tumor grade, diameter, number of tumors, pT category, pN category, UICC-stage, and year of diagnosis only pN category and number of tumors proved to be independent statistically significant predictors of 5-year survival after diagnosis, especially age was Conclusion: As expected, the proportion of patients with more than 70 years of age is rising. We could demonstrate that older age does not impair short term and long-term results. Multivariate analysis suggests that the low survival rates of the younger patients are due to the higher number of intrahepatic lesions and the higher frequency of lymph node metastases. Publication History Article published online: 26 September 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Bauschke, A., Altendorf-Hofmann, A., Ali-Deeb, A., Dondorf, F., Rauchfuß, F., Rohland, O., & Settmacher, U. (2024). Does patients’ age influence 5-year survival in intrahepatic cholangiocarcinoma?. Zeitschrift für Gastroenterologie, 62(09), e702-e703. https://doi.org/10.1055/s-0044-1789863

Vancouver

Bauschke A, Altendorf-Hofmann A, Ali-Deeb A, Dondorf F, Rauchfuß F, Rohland O, et al. Does patients’ age influence 5-year survival in intrahepatic cholangiocarcinoma?. Zeitschrift für Gastroenterologie. 2024;62(09):e702-e703. doi:10.1055/s-0044-1789863

BibTeX
@article{Bauschke2024,
  author = {Bauschke, A. and Altendorf-Hofmann, A. and Ali-Deeb, A. and Dondorf, F. and Rauchfuß, F. and Rohland, O. and Settmacher, U.},
  title = {Does patients’ age influence 5-year survival in intrahepatic cholangiocarcinoma?},
  journal = {Zeitschrift für Gastroenterologie},
  year = {2024},
  volume = {62},
  number = {09},
  pages = {e702--e703},
  doi = {10.1055/s-0044-1789863}
}
Kostenlos starten →